References

• Meyers, B. S., Flint, A. J., Rothschild, A. J., Mulsant, B. H., Whyte, E. M., Peasley-Miklus, C., Papademetriou, E., Leon, A. C., Heo, M., & STOP-PD Group (2009). A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Archives of general psychiatry, 66(8), 838–847. https://doi.org/10.1001/archgenpsychiatry.2009.79
• Flint, A. J., Meyers, B. S., Rothschild, A. J., Whyte, E. M., Alexopoulos, G. S., Rudorfer, M. V., Marino, P., Banerjee, S., Pollari, C. D., Wu, Y., Voineskos, A. N., Mulsant, B. H., & STOP-PD II Study Group (2019). Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial. JAMA, 322(7), 622–631. https://doi.org/10.1001/jama.2019.10517
• Rubin R. (2020). Postpartum Depression Persists Longer Than Previously Thought. JAMA, 324(24), 2475. https://doi.org/10.1001/jama.2020.24649
• van Bronswijk, S., Moopen, N., Beijers, L., Ruhe, H. G., & Peeters, F. (2019). Effectiveness of psychotherapy for treatment-resistant depression: a meta-analysis and meta-regression. Psychological medicine, 49(3), 366–379. https://doi.org/10.1017/S003329171800199X
• Rhee, T. G., Shim, S. R., Forester, B. P., Nierenberg, A. A., McIntyre, R. S., Papakostas, G. I., Krystal, J. H., Sanacora, G., & Wilkinson, S. T. (2022). Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis. JAMA psychiatry, 79(12), 1162–1172. https://doi.org/10.1001/jamapsychiatry.2022.3352
• Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA, 297(15), 1683–1696. https://doi.org/10.1001/jama.297.15.1683
• Hutner, L. A., Catapano, L. A., Nagle-Yang, S. M., Williams, K. E., & Osborne, L. M. (Eds.). (2022). Textbook of women’s reproductive mental health. American Psychiatric Association Publishing. [Reprinted in Psychiatric News].
• By the 2023 American Geriatrics Society Beers Criteria® Update Expert Panel (2023). American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 71(7), 2052–2081. https://doi.org/10.1111/jgs.18372
• Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023). Major depressive disorder. Nature reviews. Disease primers, 9(1), 44. https://doi.org/10.1038/s41572-023-00454-1
• Nuñez, N. A., Joseph, B., Pahwa, M., Kumar, R., Resendez, M. G., Prokop, L. J., Veldic, M., Seshadri, A., Biernacka, J. M., Frye, M. A., Wang, Z., & Singh, B. (2022). Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis. Journal of affective disorders, 302, 385–400. https://doi.org/10.1016/j.jad.2021.12.134
• World Health Organization. (2024). Depression. https://www.who.int/news-room/fact-sheets/detail/depression
• National Institute of Mental Health. (2023). Major depression. U.S. Department of Health and Human Services, National Institutes of Health. https://www.nimh.nih.gov/health/statistics/major-depression
• Centers for Disease Control and Prevention. (2024). Suicide data and statistics. https://www.cdc.gov/suicide/facts/index.html
• Gaspersz, R., Lamers, F., Kent, J. M., Beekman, A. T. F., Smit, J. H., van Hemert, A. M., Schoevers, R. A., & Penninx, B. W. J. H. (2017). Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment. Journal of psychiatric research, 84, 41–48. https://doi.org/10.1016/j.jpsychires.2016.09.018
• Thase, M. E., Weisler, R. H., Sloan, J. H., & Trivedi, M. H. (2017). Utilizing the DSM-5 anxious distress specifier to develop treatment strategies for patients with major depressive disorder. The Journal of Clinical Psychiatry, 78(6), e694–e701. https://doi.org/10.4088/JCP.ot17015ah1
• Stewart, J., McGrath, P., Quitkin, F. et al. DSM-IV Depression with Atypical Features: Is It Valid?. Neuropsychopharmacol 34, 2625–2632 (2009). https://doi.org/10.1038/npp.2009.99
• Henkel, V., Mergl, R., Allgaier, A.-K., Kohnen, R., Möller, H.-J., & Hegerl, U. (2006). Treatment of depression with atypical features: A meta-analytic approach. Psychiatry Research, 141(1), 89–101. https://doi.org/10.1016/j.psychres.2005.07.012
• Ayvaci, E. R., Lamers, F., Gorman, A., Minhajuddin, A., Nandy, K., Goodman, L. C., Trinh, A. T., Farias, R., Shahidullah, J. D., Storch, E. A., Wakefield, S. M., Emslie, G. J., & Trivedi, M. H. (2026). Examining Features of Atypical Depression in Youth From the Texas Youth Depression and Suicide Research Network Research Registry. Journal of the American Academy of Child and Adolescent Psychiatry, 65(5), 723–735. https://doi.org/10.1016/j.jaac.2025.08.015